Published in
Elsevier, European Journal of Cancer, (100), p. 17-26
DOI: 10.1016/j.ejca.2018.05.007
Links
Tools
A phase I dose-escalation study of IMAB362 (Zolbetuximab) in patients with advanced gastric and gastro-oesophageal junction cancer
Journal article published in 2018 by
Ugur Sahin,
Martin Schuler,
Heike Richly,
Stefan Bauer 
,
Anna Krilova,
Tobias Dechow,
Markus Jerling,
Magdalena Utsch,
Christoph Rohde,
Karl Dhaene,
Christoph Huber,
Ozlem Tuereci,
Özlem Türeci
,
Anna Krilova,
Tobias Dechow,
Markus Jerling,
Magdalena Utsch,
Christoph Rohde,
Karl Dhaene,
Christoph Huber,
Ozlem Tuereci,
Özlem Türeci
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 